
Making a diagnosis of deep vein zzso zzso requires both clinical assessment and objective testing because the clinical features are zzso and investigations can be either falsely positive or zzso The initial step in the diagnostic process is to zzso patients into zzso zzso or low-risk categories using a validated clinical zzso When the clinical probability is intermediate or high and the zzso ultrasound result is positive, acute symptomatic zzso is zzso Similarly, when the probability is low and the ultrasound result is normal, zzso is ruled zzso A low clinical probability combined with a negative zzso result can also be used to rule out zzso thereby obviating the need for zzso In contrast, when the clinical assessment is zzso with the results of objective testing, serial zzso zzso or zzso is required to confirm or zzso a diagnosis of zzso Once a patient is diagnosed with an acute zzso zzso zzso zzso is the agent of choice for initial therapy and oral zzso therapy is the standard for long-term secondary zzso zzso should continue for at least 3 zzso the decision to continue treatment beyond 3 months is made by weighing the risks of zzso zzso and zzso zzso and is influenced by patient zzso zzso for associated zzso is not indicated zzso but should be performed in selected patients whose clinical features suggest an underlying zzso zzso Several new zzso with theoretical advantages over existing agents are undergoing evaluation in phase 3 studies in patients with zzso zzso 

